Home Wealth Advisor Beacon Pointe Wealth Advisors LLC Invests $603,000 in Thermo Fisher Scientific Inc. (TMO) Stock – Fairfield Current

Beacon Pointe Wealth Advisors LLC Invests $603,000 in Thermo Fisher Scientific Inc. (TMO) Stock – Fairfield Current

11 min read
0
34


Beacon Pointe Wealth Advisors LLC purchased a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,688 shares of the medical research company’s stock, valued at approximately $603,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Aries Wealth Management increased its holdings in shares of Thermo Fisher Scientific by 1.1% in the fourth quarter. Aries Wealth Management now owns 4,269 shares of the medical research company’s stock valued at $955,000 after purchasing an additional 45 shares during the period. Atlas Capital Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 5.5% in the fourth quarter. Atlas Capital Advisors LLC now owns 923 shares of the medical research company’s stock valued at $207,000 after purchasing an additional 48 shares during the period. BLB&B Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 4.2% in the fourth quarter. BLB&B Advisors LLC now owns 1,252 shares of the medical research company’s stock valued at $280,000 after purchasing an additional 51 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management increased its holdings in shares of Thermo Fisher Scientific by 1.2% in the fourth quarter. Livingston Group Asset Management CO operating as Southport Capital Management now owns 4,503 shares of the medical research company’s stock valued at $1,008,000 after purchasing an additional 53 shares during the period. Finally, BKD Wealth Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 2.3% in the fourth quarter. BKD Wealth Advisors LLC now owns 2,396 shares of the medical research company’s stock valued at $536,000 after purchasing an additional 54 shares during the period. 86.88% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific stock opened at $243.51 on Monday. The company has a current ratio of 1.71, a quick ratio of 1.23 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 1-year low of $194.51 and a 1-year high of $253.91. The company has a market capitalization of $98.03 billion, a P/E ratio of 21.90, a price-to-earnings-growth ratio of 1.60 and a beta of 1.14.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.19 by $0.06. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The firm had revenue of $6.51 billion for the quarter, compared to the consensus estimate of $6.26 billion. During the same period in the previous year, the business earned $2.79 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 12.14 earnings per share for the current fiscal year.

A number of research analysts have recently issued reports on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $271.00 target price on the stock in a report on Friday, December 7th. Cleveland Research lowered Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Thursday, October 18th. Morgan Stanley boosted their target price on Thermo Fisher Scientific from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, October 25th. BTIG Research boosted their target price on Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a report on Thursday, January 31st. Finally, Robert W. Baird lifted their price target on Thermo Fisher Scientific from $256.00 to $264.00 and gave the company an “outperform” rating in a research note on Thursday, October 25th. Three equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $275.10.

In related news, insider Gregory J. Herrema sold 17,235 shares of Thermo Fisher Scientific stock in a transaction that occurred on Thursday, November 29th. The stock was sold at an average price of $247.00, for a total value of $4,257,045.00. Following the sale, the insider now directly owns 26,446 shares in the company, valued at $6,532,162. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Tyler Jacks sold 4,772 shares of the business’s stock in a transaction on Monday, November 19th. The stock was sold at an average price of $239.75, for a total value of $1,144,087.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,607 shares of company stock worth $7,972,085. Company insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Beacon Pointe Wealth Advisors LLC Invests $603,000 in Thermo Fisher Scientific Inc. (TMO) Stock” was posted by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/02/11/beacon-pointe-wealth-advisors-llc-invests-603000-in-thermo-fisher-scientific-inc-tmo-stock.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Back-End Load

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific and related companies with MarketBeat.com’s FREE daily email newsletter.

Let’s block ads! (Why?)


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Exencial Wealth Advisors LLC Has $4.17 Million Stake in iShares Global Healthcare ETF (IXJ) – Fairfield Current

Exencial Wealth Advisors LLC boosted its position in iShares Global Healthcare ETF (NYSEAR…